18 results
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Clinical Disease ... clinical manifestation ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Vasopressors Table ... Internet Book of Critical ... Vasopressors #Properties #Table ... #Pharmacology # ... Effect #Management
Coverage of common antibiotics used in the hospital

For empiric coverage, first define the type of infection,
prior resistance. e.g ... ESBL, KPC, VRE. etc ... ampicillin #management ... #antibiogram #pharmacology ... #table #sensitivities
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
chew, or crush tablet ... mucosal #IDSA #Prevention ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
interrupted schedule (e.g ... Leishmaniasis #Prevention ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
or detachment, etc ... highlighted circle= clinical ... Treatment #COVID19 #Pharmacology ... #Table #Management
Pain, Agitation, and Delirium (PAD) in the ICU
Addressing the ICU Triad (PAD) can be accomplished through
will vary with clinical ... No pharmacologic ... be effective in preventing ... SE: prolonged QTC ... CriticalCare #diagnosis #management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
ECG is vital while ... then placed on prevention ... differential #algorithm #management ... cardiology #treatment #table ... #pharmacology
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Clinical • Under-recognized ... Management during ... Delivery • Stable ... months before 1° prevention ... support for patients clinically
Intern Pocket Cards - Antibiogram and Susceptibilities
VRE - MRSA - GRAM POSITIVES - GRAM NEGATIVES -
(e.g., UTI, bacteremia ... , etc.) ... (Use clinical data ... #antibiotics #management ... #pharmacology